Universal-Beteiligungs- und Servicegesellschaft
ACAD icon

Universal-Beteiligungs- und Servicegesellschaft’s Acadia Pharmaceuticals ACAD Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Buy
33,672
+593
+2% +$13K ﹤0.01% 1625
2026
Q1 		$736K Sell
33,079
-29,909
-47% -$715K ﹤0.01% 1612
2025
Q4 		$1.68M Buy
62,988
+15,894
+34% +$380K ﹤0.01% 1317
2025
Q3 		$1M Sell
47,094
-64,913
-58% -$1.54M ﹤0.01% 1549
2025
Q2 		$2.42M Buy
112,007
+5,111
+5% +$95K ﹤0.01% 1137
2025
Q1 		$1.78M Buy
+106,896
New +$1.94M ﹤0.01% 1253

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ACAD Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Acadia Pharmaceuticals (ACAD) stake by 1.8% in Q2 2026, buying an estimated $13K and bringing the position to 33,672 shares worth $852K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.42M in Q2 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 33,672 shares of Acadia Pharmaceuticals worth $852K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 593 Acadia Pharmaceuticals shares in Q2 2026, an estimated $13K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1625 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Acadia Pharmaceuticals position peaked at $2.42M in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.